Literature DB >> 17437828

Computerized tomographic angiography for renal donor evaluation leads to a higher exclusion rate.

Andrew M Strang1, Mark E Lockhart, Philip J Kenney, Christopher L Amling, Donald A Urban, Rizk El-Galley, John R Burns, Jan L Colli, Lee N Hammontree, Peter N Kolettis.   

Abstract

PURPOSE: We compared the exclusion rate for potential living renal donors evaluated with computerized tomography angiography and radionuclide renal scintigraphy (renal scan) vs excretory urogram, renal scan and renal arteriography.
MATERIALS AND METHODS: From March 2004 through February 2006, 603 consecutive patients were evaluated as potential living renal donors. From March 2004 through February 2005, 270 consecutive patients underwent evaluation with excretory urogram, renal scan and renal angiography (group 1). Of these patients 16 underwent computerized tomography to evaluate abnormalities detected on excretory urogram. From March 2005 through February 2006, 333 consecutive patients underwent evaluation with computerized tomography angiography and renal scan (group 2). The number of patients excluded for medical reasons and/or radiographic abnormalities was determined for the 2 groups.
RESULTS: More than twice as many patients evaluated with computerized tomography were excluded. In group 1, 7% of patients (20 of 270) were excluded from donation due to radiographic findings vs 16% (53 of 333) in group 2 (p=0.0016). Of the patients 26% and 23% were excluded from renal donation for medical reasons in groups 1 and 2, respectively (p=0.5059).
CONCLUSIONS: Multidetector row computerized tomography angiography increases the detection of incidental radiographic abnormalities as well as the renal donor exclusion rate. The increased sensitivity of computerized tomography angiography has created a dilemma for those determining patient eligibility for kidney donation because the clinical significance of many of these findings is unclear. Additional studies should address the significance of these incidental findings so that patients are not needlessly excluded from kidney donation.

Entities:  

Mesh:

Year:  2007        PMID: 17437828     DOI: 10.1016/j.juro.2007.01.007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Computed tomography identified factors that preclude living kidney donation.

Authors:  Katerina Mastrocostas; Christina M Chingkoe; Kenneth T Pace; Joseph J Barfett; Anish Kirpalani; Gevork N Mnatzakanian; Paraskevi A Vlachou; Errol Colak
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

2.  Medical evaluation of living kidney donors with nephrolithiasis: a survey of practices in the United States.

Authors:  V S Tatapudi; F Modersitzki; S Marineci; M A Josephson; D S Goldfarb
Journal:  Clin Exp Nephrol       Date:  2019-11-06       Impact factor: 2.801

Review 3.  Chronic kidney disease in kidney stone formers.

Authors:  Andrew D Rule; Amy E Krambeck; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

4.  Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults.

Authors:  Elizabeth C Lorenz; Terri J Vrtiska; John C Lieske; John J Dillon; Mark D Stegall; Xujian Li; Eric J Bergstralh; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

Review 5.  Evaluation of Deceased Kidney Donors for Renal Stone Disease: Is Computed Tomography Needed?

Authors:  Senol Tonyali; Ahmet M Aydin
Journal:  Curr Urol       Date:  2018-02-20

Review 6.  Controversies related to living kidney donors.

Authors:  Ahmed I Kamal; Ahmed M Harraz; Ahmed A Shokeir
Journal:  Arab J Urol       Date:  2011-12-09

7.  Pancreatic solid incidentalomas.

Authors:  Erwin Santo; Iddo Bar-Yishay
Journal:  Endosc Ultrasound       Date:  2017-12       Impact factor: 5.628

8.  Clinical features and prognostic impact of asymptomatic pancreatic cancer.

Authors:  Tetsuya Takikawa; Kazuhiro Kikuta; Shin Hamada; Kiyoshi Kume; Shin Miura; Naoki Yoshida; Yu Tanaka; Ryotaro Matsumoto; Mio Ikeda; Fumiya Kataoka; Akira Sasaki; Kei Nakagawa; Michiaki Unno; Atsushi Masamune
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.